University of Florida
Endocrinology, Diabetes, and Metabolism fellowship · Gainesville, FL · University of Florida programs · Program website
Internal Medicine residency here · Other fellowships: Rheumatology · Cardiovascular Disease · Gastroenterology · Pulmonary and Critical Care · Hematology and Oncology · Nephrology · Infectious Disease · Geriatric Medicine
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Florida's research in endocrinology, diabetes, and metabolism, which the program shares with other departments and affiliated hospitals.
Endocrinology, Diabetes, and Metabolism at University of Floridashared by every program there, not this program's own
Institution-level: all endocrinology, diabetes, and metabolism publications from University of Florida and affiliated institutions, since 2022. Updated 2026-11-09; refreshed daily.
Works per year · * 2026 so far
Endocrinology, Diabetes, and Metabolism research topics at University of Florida
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Florida since 2024
All endocrinology, diabetes, and metabolism papers there on OpenAlex
- Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or ObesityPiaopiao Li et al. · JAMA Network Open · 2025 · PubMed · cited 59
- Cardiovascular Effects and Tolerability of GLP-1 Receptor AgonistsMattía Galli et al. · Journal of the American College of Cardiology · 2025 · PubMed · cited 116
- Advances in Cell Replacement Therapies for DiabetesBernhard J. Hering et al. · Diabetes · 2025 · PubMed · cited 55
- GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related DementiasHuilin Tang et al. · JAMA Neurology · 2025 · PubMed · cited 110
- GLP-1RA Use and Thyroid Cancer RiskJuan Pablo Brito et al. · JAMA Otolaryngology–Head & Neck Surgery · 2025 · PubMed · cited 70
- Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risksMary E. Beste et al. · American Journal of Obstetrics and Gynecology · 2024 · PubMed · cited 66
- GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 DiabetesPiaopiao Li et al. · JAMA · 2024 · PubMed · cited 48
- Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road aheadAlessandro Grattoni et al. · Nature Reviews Endocrinology · 2024 · PubMed · cited 101
- SGLT2 inhibitors: Beyond glycemic controlIrtiza Hasan et al. · Journal of Clinical & Translational Endocrinology · 2024 · PubMed · cited 71
- Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysisAbrar Ahmad et al. · Communications Medicine · 2024 · PubMed · cited 66
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-florida-college-medicine-endo"><img src="https://openprograms.org/programs/university-florida-college-medicine-endo/badge.svg" alt="University of Florida Endocrinology, Diabetes, and Metabolism fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.